• Advertise
  • Contact Us
  • About Us
  • Supplier Directory
  • SCB YouTube
  • Login
  • Subscribe
  • Logout
  • My Profile
  • LOGISTICS
    • Air Cargo
    • All Logistics
    • Express/Small Shipments
    • Facility Location Planning
    • Freight Forwarding/Customs Brokerage
    • Global Gateways
    • Global Logistics
    • Last Mile Delivery
    • Logistics Outsourcing
    • LTL/Truckload Services
    • Ocean Transportation
    • Rail & Intermodal
    • Reverse Logistics
    • Service Parts Management
    • Transportation & Distribution
  • TECHNOLOGY
    • All Technology
    • Artificial Intelligence
    • Cloud & On-Demand Systems
    • Data Management (Big Data/IoT/Blockchain)
    • ERP & Enterprise Systems
    • Forecasting & Demand Planning
    • Global Trade Management
    • Inventory Planning/ Optimization
    • Product Lifecycle Management
    • Sales & Operations Planning
    • SC Finance & Revenue Management
    • SC Planning & Optimization
    • Sourcing/Procurement/SRM
    • Supply Chain Visibility
    • Transportation Management
  • GENERAL SCM
    • Business Strategy Alignment
    • Education & Professional Development
    • Global Supply Chain Management
    • Global Trade & Economics
    • HR & Labor Management
    • Quality & Metrics
    • Regulation & Compliance
    • SC Security & Risk Mgmt
    • Supply Chains in Crisis
    • Sustainability & Corporate Social Responsibility
  • WAREHOUSING
    • All Warehouse Services
    • Conveyors & Sortation
    • Lift Trucks & AGVs
    • Order Fulfillment
    • Packaging
    • RFID, Barcode, Mobility & Voice
    • Robotics
    • Warehouse Management Systems
  • INDUSTRIES
    • Aerospace & Defense
    • Apparel
    • Automotive
    • Chemicals & Energy
    • Consumer Packaged Goods
    • E-Commerce/Omni-Channel
    • Food & Beverage
    • Healthcare
    • High-Tech/Electronics
    • Industrial Manufacturing
    • Pharmaceutical/Biotech
    • Retail
  • THINK TANK
  • WEBINARS
    • On-Demand Webinars
    • Upcoming Webinars
  • PODCASTS
  • VIDEOS
  • WHITEPAPERS
Home » China's New Drug-Buying Program Is Causing Pain in Procurement

China's New Drug-Buying Program Is Causing Pain in Procurement

December 10, 2018
Bloomberg

China is changing the way it procures drugs in its major cities. The result: Prices are set to tumble. According to some media reports, the declines for some drugs could be as much as 90 percent. The reaction: Chinese drug stocks plunged the most in a decade on Dec. 6.

What exactly is China doing?

Eleven major cities — including Beijing, Shanghai and Guangzhou — are banding together to bulk buy drugs through a tender process. In what the government calls a pilot exercise, pharmaceutical firms were invited last month to bid for contracts to supply 31 drugs — ranging from allergy and high-blood pressure treatments to cholesterol and cancer medication. 

Here’s the thing: There’ll be just one winner for each of the drugs. The victor would then solely supply that medication to the hospitals in all 11 cities.

Why’s China doing this?

The government is overhauling its healthcare system to provide better access to quality drugs and treatment for its population. While it has already begun to import more foreign drugs and make more of them reimbursable through its national insurance plan, it also wants to contain costs. 

Since its greatest bargaining chip is the sheer volume of demand from its massive population, China has asked cities to combine drug procurement in order to glean the best prices from drug makers.

So this is bad news for pharmaceutical companies?

Yes. Both Chinese and multinational companies oppose the plan, not least because the highly competitive tender process will inevitably slash drug prices and hurt their bottom lines. Another objection: By handing the supply of a drug almost entirely to one company, the government risks quality and supply chain issues, according to Sanofi’s China country chair Jean-Christophe Pointeau. 

The majority of Chinese drugmakers rely on the cheap production of generic medications to drive revenue, which means their profit margins are already slimmer than global pharmaceuticals with research and development capabilities. Chinese healthcare stocks have gone into deep sell-offs every time new information about the plan has emerged.

Are multinational pharmaceuticals also in trouble?

Yes and no. Global drugmakers are less impacted because they rely for revenue on their pipeline of novel drugs, which have not yet been matched by generics or are still on patent. No novel drugs are in the list of 31. However, in a Chinese market quirk, foreign pharmaceuticals still do big business with Chinese hospitals on their blockbuster drugs, like Pfizer Inc.’s cholesterol medication Lipitor — even though these drugs have gone off patent. 

According to Bocom International analysts led by Kelvin Chen, Pfizer supplied 74 percent of Atorvastatin, the generic name for Lipitor, to Chinese hospitals prior to the bidding — even though other Chinese makers produce generics of it. Pfizer also still supplied 84 percent of its blood pressure medication Amlodipine to hospitals, and Novartis AG provided 81 percent of cancer treatment Imatinib.

What’s going on?

Domestic generic manufacturers are generally unable to match foreign makers on quality. That means overseas pharmaceuticals still win the lion’s share of individual hospital tenders, despite higher prices. This business is likely to disappear, though, after the tender results are announced, as the foreign pharmaceuticals are unlikely to bid low enough. 

But it’s not all bad news for Big Pharma: The Chinese government has reformed its drug approval process. That’s allowing novel drugs of multinationals in at a rapid pace — sometimes faster than in the U.S. — and creating vast new revenue streams.

RELATED CONTENT

RELATED VIDEOS

Sourcing/Procurement/SRM Supply Chain Finance & Revenue Management Global Supply Chain Management Global Trade & Economics Regulation & Compliance Healthcare Pharmaceutical/Biotech
KEYWORDS China Global Supply Chain Management Global Trade & Economics healthcare Pharmaceutical/Biotech Regulation & Compliance SC Finance & Revenue Management Sourcing/Procurement/SCM Supply Chain Analysis & Consulting
  • Related Articles

    Apple's Suppliers Accused of Causing Environmental Damage in China

    India Is Boosting Drug Ingredient Output to Pare Its Reliance on China

    Big Pharma Gets Boost As China Speeds Up New Drug Approvals

Bloomberg

Global Oil Trade Shakes Up After Fires at U.S. Fuelmakers

More from this author

Wake up to live
“Supply Chains in Crisis”
updates and the latest Supply Chain News!

Subscribe to our Daily Newsletter

Timely, incisive articles delivered directly to your inbox.

Popular Stories

  • INTERIOR OF A CHICKEN FARM, WITH WHITE CHICKENS AS FAR AS THE EYE CAN SEE

    Worst Avian Flu in U.S. History Is Hitting Poultry

    Food & Beverage
  • TWO FINGERS MANIPULATE WOODEN LETTER BLOCKS TO TURN FROM SHOWING THE WORD RECOVERY TO RESILIENCE

    Five Challenges to Supply Chain Resilience in 2023

    Supply Chain Visibility
  • A PERSON HOLDS UP A TABLET COMPUTER IN A WAREHOUSE, SUPER-IMPOSED BY A GRAPHIC SHOWING A COMPLEX WEB OF SUPPLY CHAIN ELEMENTS

    Three Post-Pandemic Actions for Repairing Global Supply Chains

    Data Management (Big Data/IoT/Blockchain)
  • A MAN IN A SUIT SHAKES HANDS WITH A WOMAN IN A HARD HAT, NEXT TO A STACK OF CONTAINERS

    Three Procurement Technology Evolutions for 2023

    Sourcing/Procurement/SRM
  • The blank stare of a child's eye who is standing behind what appears to be a wooden frame

    The Alarming Continued Rise of Modern Slavery in Supply Chains: How Procurement Can Help Reverse the Trend

    Sourcing/Procurement/SRM

Digital Edition

Scb nov 2022 sm

2022 Supply Chain Innovator of the Year

VIEW THE LATEST ISSUE

Case Studies

  • New Revenue for Cloud-Based TMS that Embeds Orderful’s Modern EDI Platform

  • Convenience Store Client Maximizes Profit and Improves Customer Service

  • A Digitally Native Footwear Brand Finds Rapid Fulfillment

  • Expanding Apparel Brand Scales Seamlessly with E-Commerce Technology

  • How a Global LSP Scaled its Security Program and Won More Business

Visit Our Sponsors

Orderful Yang Ming Alithya
Barcoding Blue Yonder BNSF Logistics
CoEnterprise Data Capture Deposco
E2open GAINSystems Generix
Geodis GEP GreyOrange
Here Honeywell Intelligrated IFM
Infor Inmar Keelvar
Kinaxis Korber Lean Solutions Group 2H
Liberty SBF Locus Robotics Logility
LogistiVIEW Lucas Systems MCA Connect
MPO Nvidia Old Dominion
OpenText ORTEC Overhaul
Parsyl PMMI QIMA
Redwood Logistics Ryder E-commerce by Whiplash Saddle Creek Logistics
Schneider Dedicated Setlog Holding AG Ship4WD
Shipwell Tecsys TGW Systems
Thomson Reuters Tive Trailer Bridge
Vecna Robotics Verity
Verusen
  • More From SCB
    • Featured Content
    • Video Library
    • Think Tank Blog
    • SupplyChainBrain Podcast
    • Whitepapers
    • On-Demand Webinars
    • Upcoming Webinars
  • Digital Offerings
    • Digital Issue
    • Subscribe
    • Manage Your Subscription
    • Newsletters
  • Resources
    • Events Calendar
    • SCB's Great Supply Chain Partners
    • Supplier Directory
    • Case Study Showcase
    • Supply Chain Innovation Awards
    • 100 Great Partners Form
  • SCB Corporate
    • Advertise on SCB.COM
    • About Us
    • Privacy Policy
    • Contact Us
    • Data Sharing Opt-Out

All content copyright ©2023 Keller International Publishing Corp All rights reserved. No reproduction, transmission or display is permitted without the written permissions of Keller International Publishing Corp

Design, CMS, Hosting & Web Development :: ePublishing